The -7351C/T Polymorphism in the TPA Gene and Ischemic Stroke Risk: A Meta-Analysis

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Sun, Xunsha ^a   Lai, Rong ^a   Li, Jiaoxing ^a   Luo, Man ^a   Wang, Yufang ^a   Sheng, Wenli ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN ISCHEMIA; CARDIOEMBOLIC STROKE; CAUCASIAN; CONTROLLED STUDY; ETHNICITY; GENE FREQUENCY; GENE FUNCTION; GENETIC VARIABILITY; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MALE; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; TISSUE PLASMINOGEN ACTIVATOR GENE;

EID: 84872260729     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0053558     Document Type: Article

References (34)

1. Furie B, Furie BC, (2008) Mechanisms of thrombus formation. N Engl J Med 359: 938-949.
2. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, et al. (1984) Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 311: 501-505.
3. Kooistra T, Schrauwen Y, Arts J, Emeis JJ, (1994) Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 59: 233-255.
4. Ladenvall P, Wall U, Jern S, Jern C, (2000) Identification of eight novel single-nucleotide polymorphisms at human tissue-type plasminogen activator (t-PA) locus: association with vascular t-PA release in vivo. Thromb Haemost 84: 150-155.
5. Ladenvall P, Johansson L, Jansson JH, Jern S, Nilsson TK, et al. (2002) Tissue-type plasminogen activator-7,351C/T enhancer polymorphism is associated with a first myocardial infarction. Thromb Haemost 87: 105-109.
6. Jannes J, Hamilton-Bruce MA, Pilotto L, Smith BJ, Mullighan CG, et al. (2004) Tissue plasminogen activator-7351C/T enhancer polymorphism is a risk factor for lacunar stroke. Stroke 35: 1090-1094.
7. Babu MS, Prabha TS, Kaul S, Al-Hazzani A, Shafi G, et al. (2012) Association of genetic variants of fibrinolytic system with stroke and stroke subtypes. Gene 495: 76-80.
8. Maguire J, Thakkinstian A, Levi C, Lincz L, Bisset L, et al. (2011) Impact of COX-2 rs5275 and rs20417 and GPIIIa rs5918 polymorphisms on 90-day ischemic stroke functional outcome: a novel finding. J Stroke Cerebrovasc Dis 20: 134-144.
9. Attia J, Thakkinstian A, Wang Y, Lincz L, Parsons M, et al. (2007) The PAI-1 4G/5G gene polymorphism and ischemic stroke: an association study and meta-analysis. J Stroke Cerebrovasc Dis 16: 173-179.
10. Armstrong CA, Bevan SN, Gormley KT, Markus HS, Koblar SA (2006) Tissue plasminogen activator-7351C/T polymorphism and lacunar stroke. Stroke 37: 329, 329-330.
11. Jood K, Ladenvall P, Tjarnlund-Wolf A, Ladenvall C, Andersson M, et al. (2005) Fibrinolytic gene polymorphism and ischemic stroke. Stroke 36: 2077-2081.
12. Tuttolomondo A, Di Raimondo D, Forte GI, Casuccio A, Vaccarino L, et al. (2012) Single nucleotide polymorphisms (SNPs) of pro-inflammatory/anti-inflammatory and thrombotic/fibrinolytic genes in patients with acute ischemic stroke in relation to TOAST subtype. Cytokine 58: 398-405.
13. Horsley T, Dingwall O, Sampson M (2011) Checking reference lists to find additional studies for systematic reviews. Cochrane Database Syst Rev DOI: 10.1002/14651858. MR000026.pub 2.
14. Begg CB, Mazumdar M, (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50: 1088-1101.
15. Egger M, Davey SG, Schneider M, Minder C, (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634.
16. Geng Z, Sun XJ, Shen J, Chen JJ, Duan H, et al. (2008) The Study of Tissue Plasminoge Activator-7351C/T Enhancer Polymorphism on the Risk of Cerebral Infarction. Chin J Clin Neurosci 16: 134-138.
17. Wang YY, Wang PH, Wang DW (2006) The Relationship between the Single Nucleotide Polymorphism of the Fibrinolytic Gene and Ischemic Stroke in Chinese. Huazhong University of Science and Technology. Available: http://www.cnki.net/.
18. Adams HJ, Bendixen BH, Kappelle LJ, Biller J, Love BB, et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41.
19. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C, (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337: 1521-1526.
20. Macko RF, Kittner SJ, Epstein A, Cox DK, Wozniak MA, et al. (1999) Elevated tissue plasminogen activator antigen and stroke risk: The Stroke Prevention In Young Women Study. Stroke 30: 7-11.
21. Kristensen B, Malm J, Nilsson TK, Hultdin J, Carlberg B, et al. (1998) Increased fibrinogen levels and acquired hypofibrinolysis in young adults with ischemic stroke. Stroke 29: 2261-2267.
22. Ridker PM, Hennekens CH, Stampfer MJ, Manson JE, Vaughan DE, (1994) Prospective study of endogenous tissue plasminogen activator and risk of stroke. Lancet 343: 940-943.
23. Wardlaw JM, Warlow CP, Counsell C, (1997) Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke. Lancet 350: 607-614.
24. Sharma VK, Ng KW, Venketasubramanian N, Teoh HL, Chan BP, (2012) Intravenous thrombolysis for acute ischemic stroke in Asia. Expert Rev Neurother 12: 209-217.
25. Olson DM, Constable M, Britz GW, Lin CB, Zimmer LO, et al. (2011) A qualitative assessment of practices associated with shorter door-to-needle time for thrombolytic therapy in acute ischemic stroke. J Neurosci Nurs 43: 329-336.
26. Jern C, Ladenvall P, Wall U, Jern S, (1999) Gene polymorphism of t-PA is associated with forearm vascular release rate of t-PA. Arterioscler Thromb Vasc Biol 19: 454-459.
27. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K, (2002) A comprehensive review of genetic association studies. Genet Med 4: 45-61.
28. Wacholder S, Chanock S, Garcia-Closas M, El GL, Rothman N, (2004) Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96: 434-442.
29. Ihle-Hansen H, Thommessen B, Wyller TB, Engedal K, Fure B, (2012) Risk factors for and incidence of subtypes of ischemic stroke. Funct Neurol 27: 35-40.
30. Lee B, Anekthananon T, Poungvarin N, Nilanont Y, (2012) Etiology and risk factors of stroke in HIV-infected patients in Siriraj Hospital: a case-control study. J Med Assoc Thai 95Suppl 2: S227-S234.
31. Roquer J, Cuadrado-Godia E, Giralt-Steinthauer E, Jimena S, Jimenez-Conde J, et al. (2012) Previous infection and stroke: a prospective study. Cerebrovasc Dis 33: 310-315.
32. Bellenguez C, Bevan S, Gschwendtner A, Spencer CC, Burgess AI, et al. (2012) Genome-wide association study identifies a variant in HDAC9 associated with large vessel ischemic stroke. Nat Genet 44: 328-333.
33. Holliday EG, Maguire JM, Evans TJ, Koblar SA, Jannes J, et al. (2012) Common variants at 6p21.1 are associated with large artery atherosclerotic stroke. Nat Genet 44: 1147-1151.
34. Del BA, Palumbo V, Lamassa M, Saia V, Piccardi B, et al. (2012) Progressive lacunar stroke: review of mechanisms, prognostic features, and putative treatments. Int J Stroke 7: 321-329.